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Supplementary Figure 1 Decreasing the cell-to-cell variation also decreases the culture-to-culture variation. When screening by flow cytometry, 
screening efficiency is determined by the coefficient of variation (CV) between replicate cultures. Expression noise within a single population affects the 
precision with which the mean can be determined and therefore the CV. For each of the screening constructs shown in Figure 2 (A: plasmid-GAL, B: 
plasmid-TEF, C: integrated-TEF), replicate cultures (n=32) were grown in the presence of varying amounts of theophylline and the geometric mean 
fluorescence of each culture was determined by flow cytometry. The relative fluorescence is the ratio of the geometric mean fluorescence for a single 
culture relative to the average geometric mean for all 32 uninduced cultures. The histograms show raw geometric means and the curves are fit to a 
normal distribution. The average CV of the three populations decreases from 5.0% (A) to 3.8% (B) and finally to 2.7% (C).
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Supplementary Figure 2 One color fluorescence response histograms. (A) Fluorescence histogram of CSY492 grown in the presence of 
theophylline, caffeine, or water. The screening strain has a graded response to theophylline and no response to caffeine. (B) Fluorescence 
histograms of CSY492 containing active (green) and inactive (blue) versions of yCDM1. The fluorescence increases when caffeine is added to 
cells containing the active enzyme but is unchanged when caffeine is added to cells with the inactive enzyme. (C) Fluorescence histograms of 
CSY492 containing yCDM1 (green) and yCDM6 (blue). The more active enzyme produces a larger increase in fluorescence upon addition of 
caffeine.
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Supplementary Figure 3 Screening single cells by FACS is less sensitive than screening clonal cultures by flow cytometry. (A) When screening clonal 
cultures by flow cytometry, screening efficiency is determined by the coefficient of variation (CV) between replicate cultures. Replicate cultures of cells 
(n=10) containing the theophylline biosensor were grown in variable amounts of theophylline and analyzed by flow cytometry. The relative fluorescence 
is calculated as the ratio of the geometric mean fluorescence of a single culture to the average of the geometric mean fluorescence of all ten uninduced 
cultures. The histograms show raw geometric means, and the curves are fit to a normal distribution. The sensor has a CV of ~2.1%, allowing accurate 
discrimination of cultures with mean fluorescence differences of <10%. (B) When screening single cells by FACS, the efficiency is determined by the 
intrinsic noise within a population distribution relative to the difference in population means. Using our optimized sensor, the variation within a population 
is relatively constant, so the efficiency is strongly dependent on the ratio of fluorescence between the populations being separated. A switch with a 
larger dynamic range would improve the sorting efficiency, while additional intrinsic noise would reduce the efficiency. Cells containing the two-color 
screening system were grown in variable amounts of theophylline and analyzed by two-color flow cytometry. A representative sorting gate captured a 
small fraction of the uninduced cells (<0.1%) and increasing amounts of the more highly fluorescent populations. The ratio of these two percentages 
gives the predicted enrichment. The relative fluorescence is the ratio of the geometric mean fluorescence of the sample population to the geometric 
mean fluorescence of the uninduced control. The curve shown is an exponential fit to the experimental data. Screening single cells by FACS is highly 
effective when the changes in mean fluorescence are large, but this method cannot efficiently discriminate between small changes in mean fluores-
cence. (C) Improved enzymes produce more theophylline, which gives a larger fold activation of the RNA switch and, therefore, a better screening 
efficiency. Theophylline accumulation and switch activation are plotted for each of the enzymes described in this work. The fluorescence change is the 
increase in fluorescence of cells containing a given enzyme and grown with 1 mM caffeine relative to the same cells grown in the absence of caffeine 
([Fcaf-Fwater]/Fwater). The lines are a guide to the eye.
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Supplementary Figure 4 Changing the plasmid copy number does not significantly affect enzymatic activity. (A) A Western blot demonstrates 
that total enzyme expression does not change as the DNA copy number is decreased. The enzyme contains a C-terminal V5 epitope, and the 
anti-actin antibody is used as a loading control. The relative expression values are calculated as the ratio of anti-V5 intensity/anti-actin intensity, 
normalized to yCDM6-High. The blot shown is representative of three independent experiments. (B) Total theophylline production differs by less 
than 10% between yCDM6-High (green) and yCDM6-Low (blue). Theophylline elutes at 0.70 minutes. (C) Fluorescence response histograms for 
yCDM6-High (green) and yCDM6-Low (blue). For each cell, the GFP fluorescence is normalized by the electronic volume (EV). Despite the 
similar levels of theophylline production, the low copy expression system shows a smaller change in fluorescence, presumably indicating lower 
theophylline per cell. (D) Growth curves for cells containing empty plasmid (black), yCDM6-High (green), yCDM6-Low (blue), or an inactive 
mutant (Neeli et al., 2005) of yCDM1 (brown). The curves are an exponential fit to the data. High-copy enzyme expression causes a significant 
decrease in growth rate. Lowering the plasmid copy number relieves ~80% of the growth inhibition. While the cells with the low expression 
system may produce less theophylline per cell, they grow faster and therefore have more time to make theophylline, resulting in similar total 
production.
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Supplementary Figure 5 Representative HPLC data. Cells containing each enzyme were grown in the presence of 1 mM caffeine. Culture 
supernatants were analyzed after 24 hours using HPLC analysis. Theophylline elutes at 0.70 minutes and paraxanthine elutes at 0.63 minutes. 
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Supplementary Figure 6 Raw T50 curves. Crude E. coli lysate containing each enzyme was incubated for 10 minutes at the indicated 
temperature and then cooled on ice. 140 µL of enzyme was mixed with 20 µL of 20 mM NADPH and 40 µL of 25 mM caffeine. The residual 
theophylline production was measured by HPLC and normalized by the activity of lysate incubated at 4 oC. The data were fit to an Arrhenius 
inactivation curve, and the T50 was calculated as the temperature at which the fit showed 50% residual activity. The error bars show ± one 
standard deviation, calculated from three technical replicates. Note that these measurements for yCDM5 were an outlier, and replicate 
measurements did not show a statistically significant difference in T50 between yCDM3 through yCDM8.
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Supplementary Figure 7 Plasmid maps. (A) pCS2223, the single color integration vector used to construct CSY492. (B) 
pCS2224, the dual color integration vector used to construct CSY820. (C) pCS2172, the E. coli expression vector with yCDM1, 
used for T50 measurements. (D) pCS2155, the high copy yeast expression vector with yCDM1. (E) pCS2167, the low copy yeast 
expression vector with yCDM6. (F) The sequence and predicted structure of L2B8 (adapted from Win and Smolke, 2007).
Supplementary Table 1: Primers used in this study 
Primer Name Primer Sequence 
BM3-FromWori-FWD 5’-TATAGAATTCGATATCAAGCTTGGAGATCTAAAAGAA 
AACAATGACAATTAAAGAAATGCCTCAG-3’ 
BM3-FromWori-REV 5’-CTATGCGGCCGCTCACCCAGCCCACACGTCTTTTG-3’ 
TEF-FWD 5’-ACTTCTTGCTCATTAGAAAGAAAGC-3’ 
yCDM-CEN-REV 5’-TATACCTAGGCTTCAATGGTGGTGGTGATGG-3’ 
yCDM-ToWori-FWD 5’-AATTGGATCCATCGATGCTTAGGAGGTCATATGTCTA 
TCAAAGAAATGCCAC-3’ 
yCDM-ToWori-REV 5’-TAATGAATTCTCAATGGTGGTGGTGATGGTG-3’ 
yMutF 5’-TCTTGCTCATTAGAAAGAAAGCATAGCAATCTAATC 
TAAGTTTTAATTAC-3’ 
yMutR 5’-AATCTAGCAGTAACTCTGTTGACGATACCTTCGTAGT 
TTCTTGGAATAAC-3’ 
30R 5’-CTTAAAGATTTCACCCAATTCGTCAGCAATTTTCATC-3’ 
30F 5’-GATGAAAATTGCTGACGAATTGGGTGAAATCTTTAAG-3’ 
60R 5’-CAAGTTCTTGTCGAATCTAGATTCATCACAAGCTTCC-3’ 
60F 5’-GGAAGCTTGTGATGAATCTAGATTCGACAAGAACTTG-3’ 
61R 5’-CAAGTTCTTGTCGAATCTAGATTCATCACAAGC-3’ 
61F 5’-GCTTGTGATGAATCTAGATTCGACAAGAACTTG-3’ 
85R 5’-CAGTTCTTTTCGTGGGTCCAGGAAGTGGCCAAACCG-3’ 
85F 5’-CGGTTTGGCCACTTCCTGGACCCACGAAAAGAACTG-3’ 
216R 5’-GGAGGCCTTTCTGTCAGCGATGATCTTGTCAAC-3’ 
216F 5’-GTTGACAAGATCATCGCTGACAGAAAGGCCTCC-3’ 
329R 5’-GTGTCTTCCTTAGCGTACAAAGAGAACCATGG-3’ 
329F 5’-CCATGGTTCTCTTTGTACGCTAAGGAAGACAC-3’ 
341R 5’-CACCCTTTTCCAATGGGTATTCACCACCCAAG-3’ 
341F 5’-CTTGGGTGGTGAATACCCATTGGAAAAGGGTG-3’ 
396R 5’-GCGAATTGTTGACCGATACAGGCTCTTTGACCG-3’ 
396F 5’-CGGTCAAAGAGCCTGTATCGGTCAACAATTCGC-3’ 
481R 5’-CCATGTTAGAACCGTACAAAACCAACAATG-3’ 
481F 5’-CATTGTTGGTTTTGTACGGTTCTAACATGG-3’ 
535R 5’-GCGTTATCTGCTGGATGACCGTTGTAGG-3’ 
535F 5’-CCTACAACGGTCATCCAGCAGATAACGC-3’ 
570R 5’-CCCAGTTTTTATCACCA-3’ 
570F 5’-TGGTGATAAAAACTGGG-3’ 
586R 5’-CACCCTTAGCAGCCAAAGTTTCGTC-3’ 
586F 5’-GACGAAACTTTGGCTGCTAAGGGTG-3’ 
663R 5’-CAATTCCTTGGAGGCAACGACGTTGGTAGAG-3’ 
663F 5’-CTCTACCAACGTCGTTGCCTCCAAGGAATTG-3’ 
 
Supplementary Table 2: Plasmids and strains constructed in this study 
Strain Genotype 
W303 MATα leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 
CSY492 W303 lys2::PTEF-GFP-L2Bulge8-ADH1T 
CSY820 W303 lys2:: PTEF-mCherry-CYC1T-PTEF-GFP-L2Bulge8-ADH1T 
pCS1423 Centromeric TRP PTEF-GFP-L2Bulge8-ADH1T 
pCS1767 Centromeric URA PGAL-GFP-L2Bulge8-ADH1T 
pCS2155 2μ URA PTEF-yCDM1 
pCS2156 2μ URA PTEF-yCDM2a 
pCS2157 2μ URA PTEF-yCDM2b 
pCS2158 2μ URA PTEF-yCDM2c 
pCS2159 2μ URA PTEF-yCDM2d 
pCS2160 2μ URA PTEF-yCDM3 
pCS2161 2μ URA PTEF-yCDM4a 
pCS2162 2μ URA PTEF-yCDM4b 
pCS2163 2μ URA PTEF-yCDM4c 
pCS2164 2μ URA PTEF-yCDM4d 
pCS2165 2μ URA PTEF-yCDM5 
pCS2166 2μ URA PTEF-yCDM6 
pCS2167 Centromeric URA PTEF-yCDM6 
pCS2168 Centromeric URA PTEF-yCDM7 
pCS2169 Centromeric URA PTEF-yCDM8 
pCS2170 2μ URA PTEF-yCDM1 (A264H) 
pCS2172 pCWori + yCDM1 
pCS2173 pCWori + yCDM3 
pCS2174 pCWori + yCDM5 
pCS2175 pCWori + yCDM6 
pCS2176 pCWori + yCDM7 
pCS2177 pCWori + yCDM8 
pCS2223 pIS385 + Centromeric URA PTEF-yCDM6 
pCS2224 pIS385 + PTEF-mCherry-CYC1T-PTEF-GFP-L2Bulge8-ADH1T 
CSY821 CSY492+pCS2155 
CSY822 CSY492+pCS2160 
CSY823 CSY492+pCS2165 
CSY824 CSY492+pCS2166 
CSY825 CSY492+pCS2167 
CSY826 CSY492+pCS2168 
CSY827 CSY492+pCS2169 
CSY828 CSY492+pCS2170 
CSY829 CSY492+pCS2171 
CSY830 CSY492+pCS4 (empty centromeric plasmid) 
CSY831 CSY492+pCS31 (empty 2μ plasmid) 
CSY845 W303+pCS1767 
CSY846 W303+pCS1423 
 
Supplementary Table 3: Mutations in the BM3 enzyme variants generated in this study 
Enzyme Mutations 
yCDM1 A74W, V78I, A82L, F87A, M185V, L188W, A328F, A330W 
yCDM2a yCDM1 + I58T, P461L, A575V 
yCDM2b yCDM1 + N522S, C569Y 
yCDM2c yCDM1 + T22R, D194N, Q387R, A603T 
yCDM2d yCDM1 + S72F, P301L, G457D 
yCDM3 yCDM1 + S72F, A603T 
yCDM4a yCDM3 + M354L, T576R, Q673K 
yCDM4b yCDM3 + F72I, T339I 
yCDM4c yCDM3 + R47S 
yCDM4d yCDM3 + Q27H, G660D 
yCDM5 yCDM3 + Q27H, R47S, F72I 
yCDM6 yCDM5 + E435G 
yCDM7 yCDM6 + I174V 
yCDM8 yCDM7+A87S 
  
Supplementary Table 4: Summary of functional characterization data for enzyme variants 
Enzyme Relative  
vmax, app/KM, 
app 
KM, app (mM) T50 (°C) Selectivity 
yCDM1    1.0 1.5   ±0.1 47.0 ± 0.6    10.3 ±  0.5  
yCDM3  3.9 ±0.4 1.1 ±0.1 42.9 ± 0.9    14 ±  1 
yCDM5  12.2 ±1.0 0.75 ±0.10 41.5 ± 1.3    23 ±  3 
yCDM6  22.1 ±1.6 0.59 ±0.01 42.8 ± 1.0  100 ±25 
yCDM7  26.6 ±3.1 0.74 ±0.02 42.1 ± 1.3  175 ±  4 
yCDM8  33.0 ±4.2 0.69 ±0.04 43.1 ± 0.7  230 ±20 
 
 
